etiocholanolone has been researched along with Neoplasms in 19 studies
Etiocholanolone: The 5-beta-reduced isomer of ANDROSTERONE. Etiocholanolone is a major metabolite of TESTOSTERONE and ANDROSTENEDIONE in many mammalian species including humans. It is excreted in the URINE.
3alpha-hydroxy-5beta-androstan-17-one : An androstanoid that is 5beta-androstane substituted by an alpha-hydroxy group at position 3 and an oxo group at position 17. It is a metabolite of testosterone in mammals.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, characterization of the UGT1A locus and genetic studies directed at understanding the role of bilirubin glucuronidation and the biochemical basis of the clinical symptoms found in unconjugated hyperbilirubinemia have uncovered the structural gene polymorphisms associated with Crigler-Najjar's and Gilbert's syndrome." | 4.80 | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. ( Strassburg, CP; Tukey, RH, 2000) |
| "Dehydroepiandrosterone (DHEA) is a naturally occurring steroid synthesized in the adrenal cortex, gonads, brain, and gastrointestinal tract, and it is known to have chemopreventive and anti-proliferative actions on tumors." | 1.32 | Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines. ( Fujimoto, Y; Fukushima, S; Honda, A; Matsuzaki, Y; Miyazaki, H; Salen, G; Takagiwa, A; Tanaka, N; Yoshida, S, 2003) |
| "In patients with breast and prostate cancer hormone excretion patterns differ in a similar way from patterns in persons without cancer." | 1.24 | HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL. ( HOPKINS, CE; MARMORSTON, J; STERN, E; WEINER, JM, 1964) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (89.47) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tukey, RH | 1 |
| Strassburg, CP | 1 |
| Yoshida, S | 1 |
| Honda, A | 1 |
| Matsuzaki, Y | 1 |
| Fukushima, S | 1 |
| Tanaka, N | 1 |
| Takagiwa, A | 1 |
| Fujimoto, Y | 1 |
| Miyazaki, H | 1 |
| Salen, G | 1 |
| PESONEN, S | 1 |
| MIKKONEN, R | 1 |
| HELLMAN, L | 1 |
| ZUMOFF, B | 1 |
| COHN, ML | 1 |
| SAKAMOTO, A | 1 |
| FRANCIS, KC | 1 |
| CLARK, DG | 1 |
| FUKUSHIMA, DK | 1 |
| GALLAGHER, TF | 1 |
| TRETBAR, HA | 1 |
| CAWLEY, LP | 1 |
| NILSSON, SE | 1 |
| ARPELS, C | 1 |
| BABCOCK, VI | 1 |
| SOUTHAM, CM | 1 |
| BENARD, H | 1 |
| BOURDIN, JS | 1 |
| TAGLIANTESARACINO, R | 1 |
| SEEMAN, A | 1 |
| STERN, E | 1 |
| HOPKINS, CE | 1 |
| WEINER, JM | 1 |
| MARMORSTON, J | 1 |
| WEST, CD | 1 |
| KUMAGAI, LF | 1 |
| SIMONS, EL | 1 |
| DOMINGUEZ, OB | 1 |
| BERLINER, DL | 1 |
| SCHUBERT, K | 1 |
| BACIGALUPO, G | 1 |
| Vogel, JM | 2 |
| Yankee, RA | 1 |
| Kimball, HR | 2 |
| Wolff, SM | 2 |
| Perry, S | 2 |
| Brubaker, LH | 1 |
| Johnson, CA | 1 |
| Barnes, A | 1 |
| Rosenstein, DL | 1 |
| Hewett, JE | 1 |
| Garnham, JR | 1 |
| Bulbrook, RD | 1 |
| Wang, DY | 1 |
| Karjalainen, J | 1 |
| Wasastjerna, C | 1 |
| Bodansky, O | 1 |
| Gino, GC | 1 |
| Bumma, C | 1 |
| Calciati, A | 1 |
| La Grotta, G | 1 |
| Sala, A | 1 |
1 review available for etiocholanolone and Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; | 2000 |
18 other studies available for etiocholanolone and Neoplasms
| Article | Year |
|---|---|
Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines.
Topics: Cell Division; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, D | 2003 |
Observations on the significance of dehydroepiandrosterone, androsterone and etiocholanolone determinations in the differential diagnosis of certain adrenal and ovarian diseases.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Androgens; Androsterone; Dehydroepiandrosterone; Diagnosis, | 1958 |
An anti-tumor property of etiocholanolone in man.
Topics: Anatomy; Antineoplastic Agents; Etiocholanolone; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large | 1962 |
CUSHING'S SYNDROME.
Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Androgens; Androsterone; Carcinoma; Carcinoma, Broncho | 1963 |
[PERIODICALLY APPEARING DISEASE SYMPTOMS].
Topics: 17-Ketosteroids; Agranulocytosis; Communicable Diseases; Edema; Endocrinology; Etiocholanolone; Fami | 1963 |
EFFECT OF STEROIDS ON HUMAN CELL CULTURES; SUSTAINING EFFECT OF HYDROCORTISONE.
Topics: 17-Ketosteroids; Androsterone; Dehydroepiandrosterone; Estradiol; Etiocholanolone; Hydrocortisone; H | 1964 |
[INFLUENCE OF TESTOSTERONE ADMINISTRATION ON PLASMA 17-KETOSTEROID LEVELS].
Topics: 17-Ketosteroids; Androsterone; Etiocholanolone; Neoplasms; Pharmacology; Plasma; Testosterone | 1964 |
HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Aged; Androsterone; Breast Neoplasms; Creatine; Creatinine | 1964 |
ADRENOCORTICAL CARCINOMA WITH FEMINIZATION AND HYPERTENSION ASSOCIATED WITH A DEFECT IN 11-BETA-HYDROXYLATION.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acne Vulgaris; Adrenal Cortex Hormones; Adrenal Gland Ne | 1964 |
DIFFERENCES OF STEROID METABOLISM IN BREAST CANCER AFTER HORMONE STIMULATION.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Androgens; Androsterone; Breast Diseases; Breast Neoplasms | 1964 |
The effect of etiocholanolone on granulocyte kinetics.
Topics: Bone Marrow; Bone Marrow Cells; Etiocholanolone; Female; Humans; In Vitro Techniques; Isoflurophate; | 1967 |
A new test for both neutrophil marrow reserves and intravascular survival.
Topics: Adult; Aged; Bone Marrow; Bone Marrow Cells; Cell Survival; Etiocholanolone; Female; Hematopoiesis; | 1976 |
Hormone profiles and discriminant functions in cancer.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Hormones; Breast Neoplasms; Etiocholanolone; Female; Human | 1970 |
Conjugated and unconjugated dehydroepiandrosterone, aetiocholanolone and androsterone in the peripheral plasma of patients with cancer of the breast, ovary, uterus or prostate.
Topics: Adult; Androsterone; Breast Neoplasms; Dehydroepiandrosterone; Etiocholanolone; Female; Humans; Male | 1969 |
The etiocholanolone test for prediction of the leukopenic effect of cytoxic drugs.
Topics: Adult; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Depression, Chemical; Etiocholanolone | 1973 |
Reflections on biochemical aspects of human cancer. The Lucy Wortham James Lecture.
Topics: Alkaline Phosphatase; Blood Proteins; Breast Neoplasms; Carcinoembryonic Antigen; Colonic Neoplasms; | 1974 |
Etiocholanolone in the evaluation of marrow reserves in patients receiving cytotoxic agents.
Topics: Adult; Antineoplastic Agents; Bone Marrow Examination; Burkitt Lymphoma; Child; Choriocarcinoma; End | 1967 |
[Etiocholanolone in the evaluation of bone marrow reserve in patients treated with bone marrow depressants].
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Etiocholanolone; Humans; Leukopenia; Male; Middle A | 1971 |